廣弘控股(000529.SZ):南海種禽擬1500萬元設立全資子公司 打造從化種雞產業園
格隆匯 12 月 22日丨廣弘控股(000529.SZ)公佈,為落實南海種禽獅山基地搬遷及升級工作,充分利用控股子公司佛山市南海種禽有限公司(南海種禽)從化基地的升級改造項目列入廣州市從化區農業重點項目為契機,進一步提升公司畜禽產業發展水平,南海種禽擬在南海種禽從化分公司的基礎上,在廣州市從化區出資1500萬元投資設立全資子公司“廣東南海種禽科技有限公司”(暫定名,以登記機關核准為準,以下簡稱“南海種禽科技公司”),組織和實施從化基地的全面推進升級改造,打造南海種禽從化種雞產業園。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.